Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23

Journal of Clinical Investigation

Volumn 98, Issue 6, 1996, Pages 1355-1360

  Bowles, Karla R ^a   Gajarski, Robert ^a   Porter, Patrick ^a   Goytia, Veronica ^a   Bachinski, Linda ^a   Roberts, Robert ^a   Pignatelli, Ricardo ^a   Towbin, Jeffrey A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

dilated cardiomyopathy; genetic heterogeneity; linkage

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 10Q; FAMILIAL DISEASE; GENE LOCATION; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC LINKAGE; HEART DILATATION; HUMAN; HUMAN CELL; PENETRANCE; PRIORITY JOURNAL; TANDEM REPEAT; VIRUS GENOME;

EID: 0029784361     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118922     Document Type: Article

References (64)

1. Martin Judez, V., E. Orinius, J.F. Goodwin, E.G.J. Olsen, C.M. Oakley, and Z. Pisa. 1981. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathy. Circulation. 64:437A-438a (Abstr.)
2. Sugrue, D.D., R.J. Rodeheffer, M.B. Codd, D.J. Ballard, V. Fuster, and B.J. Gersh. 1992. The clinical course of idiopathic dilated cardiomyopathy: a population based study. Ann. Intern. Med. 117:117-123.
3. Wiles, H.B., P.D. McArthur, A.B. Taylor, P.C. Gillette, D.A. Fyfe, J.P. Matthews, and L.W. Shelton. 1991. Prognostic features of children with idiopathic dilated cardiomyopathy. Am. J. Cardiol. 68:1372-1376.
4. Dec, G.W., and V. Fuster. 1994. Idiopathic dilated cardiomyopathy. N. Engl. J. Med. 331:1564-1575.
5. Monolio, T.A., K.L. Baughman, R. Rodeheffer, T.A. Pearson, J.D. Bristow, V.V. Michels, W.H. Abelmann, and W.R. Harlan. 1992. Prevalence of etiology of idiopathic dilated cardiomyopathy (Summary of a National Heart, Lung, and Blood Institute Workshop). Am. J. Cardiol. 69:1458-1466.
6. Codd, M.B., D.D. Sugrue, B.J. Gersh, and L.J. Melton. 1989. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population-based study in Olmsted County, Minnesota, 1975-1984. Circulation. 80:564-572.
7. Abelmann, W.H. 1985. Incidence of dilated cardiomyopathy. Postgrad. Med. J. 61:1123-1124.
8. Kasper, E.K., W.R.P. Agema, G.M. Hutchins, J.W. Deckers, J.M. Hare, and K.L. Baughman. 1994. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J. Am. Coll. Cardiol. 23:586-590.
9. Goodwin, J.F. 1982. The frontiers of cardiomyopathy. Br. Heart J. 48:1-18.
10. Hess, O.M., J. Turina, and H.P. Kayenbuhl. 1981. Latente kardiomyopathie-Fruhform der kongestiven kardiomyopathie. Schweiz. Med. Wochenschr. 111:1959-1962.
11. Lewis, A.B. 1994. Prognostic value of echocardiography in children with idiopathic dilated cardiomyopathy. Am. Heart J. 128:133-136.
12. Quinones, M.A., A.D. Waggoner, L.A. Reduto, J.G. Nelson, J.B. Young, W.L. Winters Jr., L.G. Ribeiro, and R.R. Miller. 1981. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 64:744-753.
13. Anderson, K.P., R.A. Freedman, and J.W. Mason. 1987. Sudden death in idiopathic dilated cardiomyopathy. Ann. Intern. Med. 107:104-106.
14. von Olshausen, K., A. Schafer, H.C. Mehmel, F. Schwartz, J. Senges, and W. Kubler. 1984. Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br. Heart. J. 51:195-201.
15. Rihal, C.S., R.A. Nishimura, L.K. Hatle, K.R. Bailey, and A.J. Tajik. 1994. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation. 90: 2772-2779.
16. Valentine, H.A., S.A. Hunt, M.B. Fowler, M.E. Billingham, and J.S. Schroeder. 1979. Frequency of familial nature of dilated cardiomyopathy and usefulness of cardiac transplantation in this subset. Am. J. Cardiol. 63:959-963.
17. Evans, R.W. 1994. Measuring the costs of heart transplantation. Primary Cardiol. 20:48-54.
18. Michels, V.V., P.P. Moll, F.A. Miller, A.J. Tajik, J.S. Chu, D.J. Driscoll, J.C. Burnett, R.J. Rodeheffer, J.H. Chesebro, and H.D. Tazelaar. 1992. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N. Engl. J. Med. 326:77-82.
19. Keeling, P.J., and W.J. McKenna. 1994. Clinical genetics of dilated cardiomyopathy. Herz. 19:91-96.
20. Kass, S., C. MacRae, H.L. Graher, E.A. Sparks, D. McNamara, H. Boudoulas, C.T. Basson, P.B. Baker III, R.J. Cody, M.C. Fishman et al. 1994. A genetic defect that causes conduction system disease and dilated cardiomyopathy maps to 1p1-1q1. Nat. Genet. 7:546-551.
21. Olson, T.M., and M.T. Keating. 1996. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J. Clin. Invest. 97:528-532.
22. Durand, J.-B., L.L. Bachinski, L.C. Bieling, G.Z. Czernuszewicz, A.B. Ahchee, Q.T. Yu, T. Tapscott, R. Hill, J. Ifegwu, A.J. Marian et al. 1995. Localisation of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation. 92:3387-3389.
23. Krajinovic, M., B. Pinamonti, G. Sinagra, M. Vatta, G.M. Severini, J. Milasin, A. Filaschi, F. Camerini, M. Giacca, and L. Mestroni. 1995. Linkage of familial dilated cardiomyopathy to chromosome 9. Am. J. Hum. Genet. 57:846-852.
24. Schultz, K.R., R.J. Gajarski, R. Pignatelli, V. Goytia, R. Roberts, L. Bachinski, and J.A. Towbin. 1995. Genetic heterogeneity in familial dilated cardiomyopathy. Biochem. Mol. Med. 56:87-93.
25. Bolhuis, P.A., G.W. Hensels, T.J.M. Hulsebos, F. Baas, and P.G. Barth. 1991. Mapping of the locus for X-linked cardioskeletal myopathy with neutropenia and abnormal mitochondria (Barth syndrome) to Xq28. Am. J. Hum. Genet. 48:481-185.
26. Towbin, J.A., J.F. Hejtmancik, P. Brink, B. Gelb, X.-M. Zhu, J.S. Chamberlain, E.R.B. McCabe, and M. Swift. 1993. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 87:1854-1865.
27. Muntoni, F., M. Cau, A. Ganau, R. Congiu, G. Arvedi, A. Mateddu, M. Marrosu, C. Cachet, G. Realdi, A. Cao, and M. Melis. 1993. Deletion of the muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329:921-925.
28. Bione, S., P. D'Adamo, E. Maestrini, A.K. Gedeon, P.A. Bolhuis, D. Toniolo. 1996. A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat. Genet. 12:385-389.
29. American Society of Echocardiography. 1989. Recommendations for quantitation of the left ventricle by two dimensional echocardiography. Am. Soc. Echocardiogr. 2:358-367.
30. Henry, W.L., J.M. Gardin, and J.H. Ware. 1980. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 62:1054-1061.
31. Neitzel, H. 1986. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet. 73:320-326.
32. Miller, S.A., D.D. Dykes, and H.F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1215.
33. Gyapay, G., J. Morisette, A. Vignal, C. Dib, C. Fizames, P. Millasseau, S. Marc, G. Bernardi, M. Lathrop, and J. Weissenbach. 1994. The 1993-94 Genethon human genetic linkage map. Nat. Genet. 7:246-339.
34. Cooperative Human Linkage Center. 1994. A comprehensive human linkage map with centimorgan density. Science (Wash. DC). 265:2049-2054.
35. Weissenbach, J., G. Gyapay, C. Dib, A. Vignal, J. Morissette, P. Millasseau, G. Vaysseix, and M. Lathrop. 1992. A second-generation linkage map of the human genome. Nature (Lond.). 359:794-801.
36. Ott, J. 1989. Computer-simulation methods in human linkage analysis. Proc. Natl Acad. Sci. USA. 86:4175-4178.
37. Weeks, D.E., J. Ott, and G.M. Lathrop. 1990. SLINK: a general simulation program for linkage anlaysis. Am. J. Hum. Genet. 47:A204.
38. Plougham, L.M., and M. Boehnke. 1989. Estimating the power of a proposed linkage study for a complex genetic trait. Am. J. Hum. Genet. 44:543-551.
39. Terwilliger, J.D., and J. Ott. 1994. Handbook of human genetic linkage. The Johns Hopkins University Press, Baltimore, MD. 243-260 pp.
40. Ott, J. 1991. Analysis of human genetic linkage. The Johns Hopkins University Press, Baltimore, MD. 1-302.
41. Lathrop, G.M., and J.-M. Lalouel. 1984. Easy calculation of lod scores and genetic risk on small computers. Am. J. Hum. Genet. 36:460-465.
42. Lathrop, G.M., J.-M. Lalouel, C. Julier, and J. Ott. 1984. Strategies for multilocus linkage analysis in humans. Proc. Natl. Acad. Sci. USA. 81:3443-3446.
43. Solomon, S.D., J.A. Jarcho, W.J. McKenna, A. Geisterfer-Lowrance, R. Germain, R. Salerni, J.G. Seidman, and C.E. Seidman. 1990. Familial hypertrophic cardiomyopathy is a gentically heterogeneous disease. J. Clin. Invest. 86:993-999.
44. Towbin, J.A., A.J. Moss, J. Robinson, R.M. Giuffre, H. Li, P.J. Schwartz, M. Lehmann, R.T. Taggart, and J.F. Hejlmancik. 1994. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: analysis of 23 families. Circulation. 90:2635-2644.
45. Thierfelder, L., H. Watkins, C. MacRae, R. Lamas, W.J. McKenna, H.-P. Vosberg, J.G. Seidman, and C.E. Seidman. 1994. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 77:701-712.
46. Wang, Q., J. Shen, I. Splawski, D. Atkinson, Z. Li, A.J. Moss, J.A. Towbin, and M.T. Keating. 1995. SCN5A mutations cause an inherited cardiac arrhythmia, long QT syndrome. Cell. 80:805-811.
47. Curran, M.E., I. Splawski, K.W. Timothy, G.M. Vincent, E.D. Green, and M. T. Keating. 1995. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 60:795-803.
48. Wang, Q., M.E. Curran, I. Splawski, T.C. Burn, J.M. Millholland, T.J. Van Raay, J. Shen, K.W. Timothy, G.M. Vincent, T. de Jager et al. 1996. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12:17-23.
49. Barth, P.O., H.R. Scholte, J.A. Berden, J.M. Van der Klei-Van Moorsel, I.E.M. Luyt-Houwen, E.T.H. Van 'T Veer-Korthof, J.J. Van der Harten, and M.A. Sobutka-Plojhar. 1983. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle, and neutrophil leukocytes. J. Neurol. Sci. 62:327-355.
50. Procacci, P.M., S.V. Savran, S.L. Schreiter, and A.L. Bryson. 1976. Prevalence of clinical mitral valve prolapse in 1169 young women. N. Engl. J. Med. 294:1086-1088.
51. Markiewicz, W., J. Stoner, E. London, S.A. Hunt, and R.L. Popp. 1976. Mitral valve prolapse in one hundred presumably healthy young females. Circulation. 53:464-473.
52. Mercer, E.N., R.L. Frye, and E.R. Giuliani. 1970. Late systolic click in non-obstructive cardiomyopathy. Br. Heart J. 32:691-695.
53. Burch, G.E., N.P. DePasquale, and J.H. Phillips. 1968. The syndrome of papillary muscle dysfunction. Am. Heart J. 75:399-415.
54. Sanyal, S.K., R.K.F. Leung, R.C. Tierney, R. Gilmartin, and S. Pitner. 1979. Mitral valve prolapse syndrome in children with Duchenne's progressive muscular dystrophy. Pediatrics. 63:116-122.
55. Weller, P.A., E.P. Ogryzko, E.B. Corben, N.I. Zhidkova, B. Patel, G.J. Price, N.K. Spurr, V.E. Koteliansky, and D.R. Critchley. 1990. Complete sequence of human vinculin and assignment of the gene to chromosome 10. Proc. Nat. Acad. Sci. USA, 87:5667-5671.
56. Koteliansky, V.E., E.P. Ogryzko, N.I. Zhidkova, P.A. Weller, D.R. Critchley, K. Vancompernolle, J. Vandekerckhove, P. Strasser, M. Way, M. Gimona, and J.V. Small. 1992. In additional exon in the human vinculin gene specifically encodes meta-vinculin-specific difference peptide. Eur. J. Biochem. 204:767-772.
57. Veyama, H., G. Bruns, and N. Kanda. 1990. Assignment of the vascular smooth muscle actin gene ACTSA to human chromosome 10. Jinrui Idengaku Zasshi. 35:145-150.
58. Kapfhamer, D., D.E. Miller, S. Lambert, V. Bennett, T.W. Glover, and M. Burmeister. 1995. Chromosomal localization of the ankyrin G gene (ANK3/ Ank3) to human 10q21 and mouse 10. Genomics.6 27:189-191.
59. Kamat, A.K., M. Rocchi, D. Smith, and O.J. Miller. 1993. Laminin A/C gene and a related sequence map to human chromosomes 1q 12.1-q23 and 10. Somatic Cell Mol. Genet. 19:203-208.
60. Webster, K.A., N.A. Oliver, and D.C. Wallace. 1982. Assignment of an oligomycin-resistance locus to human chromosome 10. Somatic Cell Mol. Genet. 8:223-244.
61. Jabs, E.W., P.J. Thomas, M. Bernstein, C. Coss, G.C. Ferreira, and P.L. Pedersen. 1994. Chromosomal localization of genes required for the terminal steps of oxidative metabolism: alpha and gamma subunits of ATP synthase and the phosphate carrier. Human Genet. 93:600-602.
62. Fink, T.M., M. Zimmer, S. Weitz, J. Tschopp, D.E. Jenne, and P. Lichter. 1992. Human perforin maps to 10q22, a region that is syntenic with mouse chromosome 10. Genomics. 13:1300-1302.
63. Weller, B., G. Karpati, and S. Carpenter. 1990. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci. 100:9-13.
64. Menke, A., and H. Jockusch. 1991. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature (Lond.). 349:69-71.